product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
p38α MAPK (7D6) Rabbit mAb
catalog :
2371
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
7D6
reactivity :
human, mouse, rat
application :
western blot
citations: 6
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig s1
Cheng H, Liang Y, Kuo Y, Chuu C, Lin C, Lee M, et al. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015;6:e1753 pubmed publisher
Sahai V, Redig A, Collier K, Eckerdt F, Munshi H. Targeting BET bromodomain proteins in solid tumors. Oncotarget. 2016;7:53997-54009 pubmed publisher
Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait Ammar A, et al. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression. PLoS Pathog. 2015;11:e1005063 pubmed publisher
Kessler T, Hache H, Wierling C. Integrative analysis of cancer-related signaling pathways. Front Physiol. 2013;4:124 pubmed publisher
Sinfield J, Das A, O Regan D, Ball S, Porter K, Turner N. p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts. Biochem Biophys Res Commun. 2013;430:419-24 pubmed publisher
Bohdanowicz M, Balkin D, De Camilli P, Grinstein S. Recruitment of OCRL and Inpp5B to phagosomes by Rab5 and APPL1 depletes phosphoinositides and attenuates Akt signaling. Mol Biol Cell. 2012;23:176-87 pubmed publisher
product information
SKU :
2371S
Product-Name :
p38α MAPK (7D6) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Western blot
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
40
Host :
Rabbit
Target :
p38-alpha MAPK
Primary-Protein :
p38-alpha
Alt-Names :
CSAID-binding protein,CSBP,CSBP1,CSBP2,CSPB1,Csaids binding protein,Cytokine suppressive anti-inflammatory drug-binding protein,EXIP,MAP kinase 14,MAP kinase MXI2,MAP kinase p38 alpha,MAPK 14,MAPK14,MAX-interacting protein 2,MK14,MXI2,Mitogen-activated protein kinase 14,Mitogen-activated protein kinase p38 alpha,PRKM14,PRKM15,RK,SAPK2A,cytokine suppressive anti-inflammatory drug binding protein,p38,p38 MAP kinase,p38 mitogen activated protein kinase,p38ALPHA,p38alpha Exip,stress-activated protein kinase 2A
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.